$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Comprehensive analysis and clinical reference of the efficacy and side effects of Asinib/Asiminib
2026-02-01 22:25:32
Check Details
Efficacy evaluation and medication recommendations of ritexitinib (Lefenox) after six months of taking it
2026-02-01 22:25:32
Check Details
Common side effects and safe medication precautions of sparsentan
2026-02-01 22:25:32
Check Details
Analysis of the latest market price and reference cost per box of Ixazomib
2026-02-01 22:25:32
Check Details
Analysis of whether Lurbinectedin has been included in medical insurance and reimbursement policies
2026-02-01 22:25:32
Check Details
Is Doxorubicin an imported drug or a domestic drug? Introduction to market supply and quality differences
2026-02-01 22:25:32
Check Details
How much does everolimus (Afinitor) need to be taken in a month? Reasonable medication cycle recommendations
2026-02-01 22:25:32
Check Details
What is estramustine (Adelox), and its main uses and indications are explained in detail
2026-02-01 22:25:32
Check Details
The latest information on Seripas (BRINEURA) price and market reference price per box
2026-02-01 22:25:32
Check Details
Which class of drugs does Eslicarbazepine belong to and its role in the treatment of epilepsy?
2026-02-01 22:25:32
Check Details
Can you continue to take Anagrelide after taking it for 20 days and safety instructions
2026-02-01 22:25:32
Check Details
Is apalutamide (Ansenko) a targeted drug and an introduction to its treatment mechanism
2026-02-01 22:25:32
Check Details
1
2
...
2147
2148
2149
2150
2151
2152
2153
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
2
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
3
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
4
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
5
Adagrasib Medication Management Guide for Special Populations
6
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
7
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
8
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
9
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
10
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
11
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
12
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma